On August 30, 2020, the 37th national pharmaceutical industry information annual conference, sponsored by China Pharmaceutical Industry Information Center, was grandly opened in Zhuhai. The conference solemnly released the list of top 100 pharmaceutical enter...

On March 25, 2019 the seventh council of CCCMHPIE was held successfully in quanzhou of Fujian, TUL as the standing director was invited to participate the meeting. CCCMHPIE commended most outstanding enterprises who got excellent exporting and importing jo...

On Oct. 16th.alist of the third batch of green manufacturing factory was published by departmentof energy conservation and comprehensive utilization, ministry of industry andinformation technology, in which there were 402 enterprises included and therewere 8 ...

Recently, amoxicillin capsule (0.25g) produced by TUL was approved by China Food and Drug Administration, passed the consistency of quality and efficacy evaluation for generic drugs (the 「Consistency Evaluation」).In March 2016, the general office of the sta...

Recently, Zhuhai United LaboratoriesCo.,Ltd(Zhongshan branch) declare the diabetes drug recombinant human insulin gene engineering series product research and development and industrialization "project won Zhuhai science and technology progress award " issued...

After a rigorous site check and evaluation of clinical test data, insulin glargine, the human insulin analog developed independently by United Lab using DNA gene recombination technology, is finally granted with the approval document today and will go to mark...